# Vitalant – FDA Inspection, Jun 19, 2019

Source: https://www.keypedia.com/records/fda_inspections/vitalant/a3002c8b-b3c5-4254-939b-d6a97c0ab620
Source feed: FDA_Inspections

> FDA inspection 1094101 of Vitalant, June 19, 2019. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 606. Form 483 issued. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1094101
- Company Name: Vitalant
- Inspection Date: 2019-06-19
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1231512 - 2024-07-11
- FDA Inspection 993571 - 2016-10-25
- FDA Inspection 984244 - 2016-08-18
- FDA Inspection 879849 - 2014-05-23
- FDA Inspection 848850 - 2013-09-12

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/richard-j-bashay/ce50702d-1f5b-42c5-b50a-88bb43cba196)

Company: https://www.keypedia.com/companies/vitalant/7fac93ca-3e09-41a7-9105-8c108be93855

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
